Denver Arthritis Clinic

Denver, Colorado 80230-7127

2 studies enrolling now · 36 studies all time

What they study most

Active Cutaneous Lupus Erythematosus, Active Idiopathic Inflammatory Myopathy, Active Rheumatoid Arthritis, Antisynthetase Syndrome, Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, Autoimmune Diseases, Autoimmunity, Inflammation, Chronic Cutaneous Lupus Erythematosus, Chronic Uncontrolled Gout, Connective Tissue Diseases

Studies at this site

• A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY) — Recruiting now
• Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease — Recruiting now
• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Running, not enrolling
• Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling
• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — Completed
• Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight — Completed
• A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis — Stopped early
• A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) — Completed
• Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate — Completed
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout — Completed
• Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) — Completed
• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease — Completed
• Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis — Completed
• Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy — Completed
• TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis — Completed
• Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome — Completed
• Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis — Stopped early
• PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed
• A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus — Completed
• Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis — Completed
• A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome — Completed
• GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera® — Completed
• A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX — Completed
• A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis — Completed
• A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis — Completed
• Methotrexate-Inadequate Response Study — Completed
• Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone — Completed
• A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate — Completed
• A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis — Stopped early
• A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis — Completed
• Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) — Completed
• A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis — Completed